Skip to main content

Year: 2023

Eyewear Market Size to reach USD 246.47 billion by 2030 | Fortune Business Insights

As per the report by Fortune Business Insights, the global Eyewear Market size is projected to reach USD 246.47 billion in 2030, at a CAGR of 6.2% during the forecast period, 2023-2030Eyewear MarketEyewear Market Forecast, 2023-2030Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) — The global eyewear market is projected to grow from USD 161.61 billion in 2023 to USD 246.47 billion by 2030, exhibiting a CAGR of 6.2% during the forecast period. The rising prevalence of vision abnormality and increasing incidence of ocular disorders, including astigmatism, myopia, and hypermetropia, will drive market growth during forecast period. Fortune Business Insights™ mentioned this in a report titled, “Eyewear Market, 2023-2030.”Request a Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/eyewear-market-101749Key...

Continue reading

Nordic Urinary Catheters Market Size to Surpass USD 111.1 Million by 2030, exhibiting a CAGR of 6.2%

As per the report by Fortune Business Insights, the global Nordic Urinary Catheters Market size is projected to reach USD 111.1 million in 2030, at a CAGR of 6.2% during the forecast period, 2023-2030 Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) — The Nordic urinary catheters market is expected to touch USD 111.1 million by 2030, recording a CAGR of 6.2% during the forecast period. . The number of people, especially the elderly population, suffering from urinary incontinence is increasing every year, which is predicted to boost the Nordic urinary catheter market growth. Fortune Business Insights™ displays this information in its research report titled “Nordic Urinary Catheters Market, 2023-2030.”Request a Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nordic-urinary-catheters-market-108559Key...

Continue reading

Intensive Care Unit (ICU) Equipment Market Size to Surpass USD 9.13 Billion in 2030, exhibiting a CAGR of 3.9%

As per the report by Fortune Business Insights, the Intensive Care Unit (ICU) Equipment Market size is projected to reach USD 9.13 Billion in 2030, at a CAGR of 3.9% during the forecast periodIntensive Care Unit (ICU) Equipment MarketIntensive Care Unit (ICU) Equipment Market (2023-2030)Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) — The global Intensive Care Unit (ICU) Equipment Market size was USD 6.84 billion in 2022, and it is projected to grow from USD 6.98 billion in 2023 to USD 9.13 billion in 2030, exhibiting a CAGR of 3.9% during the forecast period. Intensive care mainly represents the highest treatment level designated for critically ill patients with recoverable life-threatening conditions. The intensive care unit (ICU) equipment includes dialysis equipment, ventilators, pulse oximeters, catheters, pumps, tubes,...

Continue reading

Global Softgel Capsules Market Size to reach USD 10.49 Billion by 2030 | Fortune Business Insights

As per the report by Fortune Business Insights, the Softgel Capsules Market size is projected to reach USD 10.49 Billion by 2030, at a CAGR of 5.8% during the forecast periodSoftgel Capsules MarketSoftgel Capsules Market (2023-2030)Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) — The global softgel capsules market size was valued at USD 6.72 billion in 2022 and is expected to be worth USD 7.07 billion in 2023. The market is projected to reach USD 10.49 billion by 2030, recording a CAGR of 5.8% during the forecast period. Softgel capsules refers to a solid capsule that contains a liquid or semi-solid center and is consumed orally to fight several mild as well as chronic diseases. These capsules are made from gelatin, water, opacifiers, and plasticizers, such as glycerin or sorbitol. The growing incidence of acute ailments...

Continue reading

Fitness Tracker Market Size to reach USD 182.90 Billion by 2030 | Fortune Business Insights

As per the report by Fortune Business Insights, The Fitness Tracker Market size is projected to reach USD 182.90 Billion by 2030, at a CAGR of 19.1% during the forecast period.Fitness Tracker MarketFitness Tracker Market (2023-2030)Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) — The global fitness tracker market size was valued at USD 47.36 billion in 2022, and it is projected to grow from USD 53.94 billion in 2023 to USD 182.90 billion by 2030, exhibiting a CAGR of 19.1% during the forecast period. Fitness trackers are mainly used among the general population to track physical and fitness activities, such as heart rate, steps covered, sleep duration, breathing, and calories burned and consumed. These devices are synced with a computer or a smartphone and can be used to monitor fitness and health-related parameters anytime...

Continue reading

Inflammatory Bowel Disease Treatment Market to hit USD 39.19 Billion by 2030 | Fortune Business Insights

As per the report by Fortune Business Insights, the global inflammatory bowel disease treatment market size is projected to reach USD 39.19 billion by 2030, at a CAGR of 5.7% during the forecast period, 2023-2030Inflammatory Bowel Disease Treatment MarketInflammatory Bowel Disease Treatment Market Forecast, 2023-2030Pune, India, Oct. 30, 2023 (GLOBE NEWSWIRE) — The inflammatory bowel disease treatment market revenue is set to rise from USD 26.55 billion in 2023 to USD 39.19 billion by 2030 at a CAGR of 5.7% from 2023 to 2030.  Increasing prevalence of ulcerative colitis and Crohn’s disease due to environmental factors and lifestyle changes among people are driving market growth. Fortune Business Insights™ shares this information in its report titled “Inflammatory Bowel Disease Treatment Market, 2023-2030.”Key...

Continue reading

Kvika banki hf.: Publication of 9M financial results on Thursday 2 November

The Board of Directors of Kvika banki hf. is set to approve the financial statements of the Group for the first nine months of 2023 at a board meeting on Thursday 2 November. The financial statements will subsequently be published after domestic markets have closed. A meeting to present the results to shareholders and market participants will be held the same day, at 16:15 GMT on Thursday 2 November, at the bank’s headquarters on the 9th floor at Katrínartún 2, 105 Reykjavík. Ármann Þorvaldsson, CEO of Kvika, and Eiríkur Magnús Jensson, CFO of Kvika, will present the company’s financial results and key developments in the past months. Ármann will also discuss Kvika’s main projects and areas of focus going forward. The presentation will be conducted in Icelandic and will be streamed live. Further, a recording of the meeting...

Continue reading

Eyenovia to Sponsor Course on Drug Delivery Innovation at IJCAHPO’s 51st Annual Continuing Education (ACE) Program

Course to provide ophthalmic technicians with background on the Optejet dispensing technology and training on the use of Mydcombi™ for mydriasis NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic technology company commercializing Mydcombi™ for mydriasis, preparing for regulatory approval of APP130007 for relief of pain and inflammation post ocular surgery, and incorporating its advanced Optejet® device for use both in connection with its own drug-device therapeutic product candidates for presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, today announced that it is sponsoring a course during the International Joint Commission on Allied Health Personnel in Ophthalmology (IJCAHPO) 51st Annual Continuing Education (ACE) program, which...

Continue reading

Next Hydrogen Achieves Energy Efficiency Targets for its New GEN2 Water Electrolysers

MISSISSAUGA, Ontario, Oct. 30, 2023 (GLOBE NEWSWIRE) — Next Hydrogen Solutions Inc. (“Next Hydrogen”) (TSXV:NXH, OTC:NXHSF) is pleased to report that it has met its energy efficiency targets for its new second generation “GEN2” water electrolyser technology. Next Hydrogen is launching its next generation GEN2 large-scale, low-cost green hydrogen production systems. A key performance aspect is the ability to maintain good energy efficiency at high hydrogen production rates. Next Hydrogen has achieved its target cell performance of 1.90 V/cell at 1 A/cm2 and 70oC. This exceeds recently reported US Department of Energy (DOE) technical targets status for energy efficiency, while maintaining a 2 times higher peak operating point. Notably, Next Hydrogen’s 2024 targets also exceed DOE 2026 targets:Current Density DOE 2022 Status Next...

Continue reading

Neumora Therapeutics to Participate in Upcoming Conferences in November

WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) — Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced that the Company will participate in two investor conferences in November:Guggenheim Healthcare Talks 5th Annual INI Conference: Members of management will participate in a fireside chat on Monday, November 6, 2023, at 1:50 PM ET in New York, NY.Stifel 2023 Healthcare Conference: Members of management will participate in a fireside chat on Wednesday, November 15, 2023, at 11:30 AM ET in New York, NY.A live webcast of each event will be available on the events and presentations section of the Company’s website at www.neumoratx.com. A replay of the webcasts will be available following the completion of the events and will be archived...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.